Meglitinide

Megglitinide is a type of drug used to treat type 2 diabetes in adults. It works by stimulating the release of insulin from the pancreas, reducing the amount of sugar in the blood. It is usually taken once or twice daily with a meal. Common side effects may include nausea, diarrhoea, and dizziness. If any of these symptoms occur, contact your doctor

Meglitinide is a class of medication, not a single drug itself. Here's a breakdown of what Meglitinides are and how they work:

Type of Drug: Meglitinides are classified as oral blood sugar lowering drugs.

Function: They work by stimulating the pancreas to release insulin, a hormone that helps regulate blood sugar levels.

How They Work: Meglitinides target specific potassium channels within pancreatic beta cells. This closure of channels triggers the release of insulin.

Conditions Treated: Meglitinides are primarily used to manage type 2 diabetes, specifically to help control blood sugar levels after meals.

Common Meglitinide Drugs:

  • Repaglinide (Prandin)
  • Nateglinide (Starlix)

Advantages of Meglitinides:

  • May offer faster-acting blood sugar control compared to some other oral diabetes medications.
  • Short duration of action, which can minimize the risk of low blood sugar (hypoglycemia) outside of mealtimes.

Disadvantages of Meglitinides:

  • May not be as effective as other medications for some people with type 2 diabetes.
  • Can cause weight gain in some users.
  • May interact with other medications.

Important Considerations:

  • Meglitinides are typically prescribed alongside other diabetes medications or lifestyle changes like diet and exercise for optimal blood sugar control.
External Links